MiR-29c inhibits tumor growth by regulating TGFB-induced factor homeobox 2 (TGIF2), CAMP-responsive element binding protein 5 (CREB5), and V-Akt murine thymoma viral oncogene homolog 3 (AKT3). Here, TGIF2 is linked to neoplasm.